# Bioharvest Sciences Inc.: financial statements, quarterly

BHST · Nasdaq · CIK 1723464 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhst.md) · [Financials](/companies/bhst/financials.md) · [Filings](/companies/bhst/filings.md) · [Insiders](/companies/bhst/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bhst/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [5.4](/filings/0001376474-25-000299.md) | [2.4](/filings/0001376474-26-000257.md) | [23.0](/filings/0001376474-26-000257.md) |
| Current assets | $m | not reported | [9.1](/filings/0001376474-25-000299.md) | [7.9](/filings/0001376474-26-000257.md) | [30.5](/filings/0001376474-26-000257.md) |
| Total assets | $m | not reported | [15.0](/filings/0001376474-25-000299.md) | [25.0](/filings/0001376474-26-000257.md) | [47.7](/filings/0001376474-26-000257.md) |
| Current liabilities | $m | not reported | [26.5](/filings/0001376474-25-000299.md) | [14.3](/filings/0001376474-26-000257.md) | [7.7](/filings/0001376474-26-000257.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001376474-25-000299.md) | [3.9](/filings/0001376474-26-000257.md) | [0.1](/filings/0001376474-26-000257.md) |
| Shareholders' equity | $m | [(5.9)](/filings/0001376474-25-000299.md) | [(14.9)](/filings/0001376474-25-000299.md) | [1.3](/filings/0001376474-26-000257.md) | [25.4](/filings/0001376474-26-000257.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

Shares outstanding: 22,666,842 at 2025-12-31, from the cover of the [40-F filed 2026-03-31](/filings/0001376474-26-000257.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.